Sante Technology Holdings Stock (OTC: SNTE)

Latest news for Sante Technology Holdings (OTC:SNTE) Stock

Sante Technology Holdings Inc. specialises in assisting Asian entrepreneurs and value startups to access the United States capital market through services like RTO and public listings as well as serving as a Company Doctor to clients already listed on OTC and NASDAQ markets. It provides comprehensive services, including Reverse Takeovers (RTOs) and public listings, to Asia-Pacific clients. Its goal is to help, evaluate and enhance internal structure, setup, and publicly accessible information, maximizing shareholder value.

SANTE TECHNOLOGY HOLDINGS by Sante Technology Holdings Inc.

Sante Technology Holdings Inc

Wells Fargo analyst Eric Luebchow maintains American Tower (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMT#NYSE">AMT</a>) with a Overweight and raises the price target from $225 to $245.

News

Price Target

Analyst Ratings

Wells Fargo Maintains Overweight on American Tower, Raises Price Target to $245

WIIM

Northern Oil and Gas shares are trading higher after the company reported better-than-expected Q2 sales results.

Baird analyst Colin Sebastian maintains Pinterest (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PINS#NYSE">PINS</a>) with a Outperform and lowers the price target from $44 to $41.

PINS

Baird Maintains Outperform on Pinterest, Lowers Price Target to $41

Wedbush analyst David Chiaverini maintains LendingClub (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LC#NYSE">LC</a>) with a Outperform and raises the price target from $11 to $14.

Wedbush Maintains Outperform on LendingClub, Raises Price Target to $14

Wells Fargo analyst Joseph O'Dea maintains Stanley Black &amp; Decker (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SWK#NYSE">SWK</a>) with a Equal-Weight and raises the price target from $85 to $110.

Wells Fargo Maintains Equal-Weight on Stanley Black & Decker, Raises Price Target to $110

AutoNation shares are trading higher. The company reported Q2 financial results.

Baird analyst David Rescott maintains Penumbra (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PEN#NYSE">PEN</a>) with a Outperform and lowers the price target from $231 to $180.

Baird Maintains Outperform on Penumbra, Lowers Price Target to $180

Wells Fargo analyst Joseph O'Dea maintains Illinois Tool Works (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ITW#NYSE">ITW</a>) with a Underweight and raises the price target from $230 to $236.

Wells Fargo Maintains Underweight on Illinois Tool Works, Raises Price Target to $236

Wedbush analyst Richard Anderson maintains Safehold (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAFE#NYSE">SAFE</a>) with a Neutral and raises the price target from $20 to $25.

SAFE

Wedbush Maintains Neutral on Safehold, Raises Price Target to $25

Wells Fargo analyst Joseph O'Dea maintains Hubbell (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUBB#NYSE">HUBB</a>) with a Equal-Weight and raises the price target from $397 to $400.

HUBB

Wells Fargo Maintains Equal-Weight on Hubbell, Raises Price Target to $400

Wells Fargo analyst Gabe Hajde maintains Graphic Packaging Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPK#NYSE">GPK</a>) with a Underweight and raises the price target from $21 to $24.

Wells Fargo Maintains Underweight on Graphic Packaging Holding, Raises Price Target to $24

Wells Fargo analyst Matthew Akers maintains L3Harris Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LHX#NYSE">LHX</a>) with a Overweight and lowers the price target from $262 to $260.

Wells Fargo Maintains Overweight on L3Harris Technologies, Lowers Price Target to $260

Roth MKM analyst Gerry Sweeney maintains CECO Environmental (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CECO#NASDAQ">CECO</a>) with a Buy and raises the price target from $26 to $35.

CECO

Roth MKM Maintains Buy on CECO Environmental, Raises Price Target to $35

ANET

Arista Networks shares are trading higher after the company reported better-than-expected Q2 financial results and raised its Q3 revenue guidance.

Wells Fargo analyst Larry Biegelsen maintains Inari Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NARI#NASDAQ">NARI</a>) with a Overweight and lowers the price target from $84 to $65.

NARI

Wells Fargo Maintains Overweight on Inari Medical, Lowers Price Target to $65

Citigroup Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/C#NYSE">C</a>) reportedly breached a U.S. Federal Reserve rule on intercompany transactions, leading to errors in its internal liquidity reporting.
According to the document, which provides a 2023 year-end snapshot of some of Citigroup&#8217;s work on&nbsp;regulatory issues &#8220;the firm&#8217;s subsequent reaction to the breaches resulted in liquidity reporting inaccuracies,&#8221; said Reuters.
These infractions are being reported for the first time. Regulation W mandates banks limit transactions, such as loans, with their affiliates to protect depositors with government-insured funds up to $250,000.
The Regulation W violations come as Citigroup addresses other issues with its risk management and internal controls.
According to the document, the &#8220;longstanding breaches revealed weaknesses&#8221; in Citigroup&#8217;s &#8220;ability to identify, monitor, and prevent&#8221; future Regulation W violations.
Meanwhile, &#8220;proposed revisions to policies and procedures do not appear to provide sufficiently clear guidance for employees to assure compliance with the regulation.&#8221;
A bank spokesperson stated, &#8220;We are fully committed to complying with laws and regulations and have a strong Regulation W framework in place to ensure prompt identification, escalation and remediation of issues in a timely manner.&#8221;
As per the report, in 2020, authorities deemed its risk practices &#8220;unsafe and unsound,&#8221; and in 2023, the bank was criticized for how it assessed counterparty risks.
This month, Citigroup was fined $136 million for inadequate data management progress, and the bank reportedly agreed with the Bourse de Montreal to settle claims of failing to report <a target="_blank" href="https://www.benzinga.com/markets/equities/24/07/39855882/citigroup-pays-138k-fine-for-reporting-errors-report" rel="noreferrer noopener">large options contract positions</a>.
In May, British regulators imposed a hefty fine of over $78.5 million on Citigroup for its trading <a href="https://www.benzinga.com/markets/equities/24/05/38957870/uk-regulators-hit-citi-with-a-massive-79m-fine-for-trading-control-failures" target="_blank" rel="noreferrer noopener">system and control shortcomings</a>.
Citigroup stock has gained more than 36% in the past 12 months. Investors can gain access to the stock via First Trust Nasdaq Bank ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTXO#NASDAQ">FTXO</a>) and Series Portfolios Trust InfraCap Equity Income Fund ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICAP#NYSE">ICAP</a>).
C Price Action: Citigroup shares are down 0.061% at $65.86 at the last check Wednesday.
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo: Shutterstock

Equities

Large Cap

Global

Federal Reserve

FTXO

ICAP

What's Going On With Citigroup Shares Today?

Roth MKM analyst Harry Fong maintains Axis Capital Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXS#NYSE">AXS</a>) with a Buy and raises the price target from $75 to $90.

Roth MKM Maintains Buy on Axis Capital Holdings, Raises Price Target to $90

Wells Fargo analyst Mohit Bansal maintains Pfizer (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>) with a Equal-Weight and raises the price target from $28 to $30.

Wells Fargo Maintains Equal-Weight on Pfizer, Raises Price Target to $30

Wells Fargo analyst Mohit Bansal maintains Merck &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>) with a Equal-Weight and lowers the price target from $140 to $125.

Wells Fargo Maintains Equal-Weight on Merck & Co, Lowers Price Target to $125

Roth MKM analyst Rohit Kulkarni maintains Pinterest (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PINS#NYSE">PINS</a>) with a Neutral and lowers the price target from $40 to $39.

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

Comments

Sante Technology Holdings

News

Latest news for Sante Technology Holdings (OTC:SNTE) Stock